|1.||Li, Dian-Dong: 2 articles (03/2004 - 11/2002)|
|2.||Wang, Zhen: 2 articles (03/2004 - 11/2002)|
|3.||Meng, Zhuo: 1 article (02/2009)|
|4.||Jia, Fei-ge: 1 article (02/2009)|
|5.||Zhang, Xiao-dong: 1 article (02/2009)|
|6.||Xu, Yi-kai: 1 article (02/2009)|
|7.||Jiang, Jian-Ming: 1 article (03/2004)|
|8.||Liang, Yun-Yan: 1 article (11/2002)|
|9.||Cai, Nian-Sheng: 1 article (11/2002)|
|10.||Wang, Dai-Shu: 1 article (11/2002)|
|1.||Brain Injuries (Brain Injury)
03/01/2004 - "To investigate whether two kinds of in vitro prepared advanced glycation end products (AGEs), Glu-BSA and Gal-BSA, could change oxidation stress and anti-oxidation abilities in astrocytes, and thus might contribute to brain injury. "
11/01/2002 - "To investigate whether two kinds of in vitro prepared advanced glycation end products (AGE), Glu-BSA and Gal-BSA, could induce proinflammatory mediators IL-1beta and TNF-alpha, as well as oxidative stress and nitric oxide (NO), in astrocytes, thus contributing to brain injury. "
02/01/2009 - "Gal-BSA-SPIO can specifically bind to ASG receptors on hepatocyte membrane to improve the tumor-liver contrast-to-noise ratio."
02/01/2009 - "The signal intensities of the tumors did not exhibit obvious changes after the administration of SPIO or Gal-BSA-SPIO. "
02/01/2009 - "The size of the Gal-BSA-SPIO particles was 34.4 nm. The 20 rabbits bearing VX2 tumor, with tumor size ranging from 3 mm to 12 mm, showed isointense signal in the liver and hypointense signal in the tumor on T1WI, and isointense signal in the liver and slightly hyperintense signal in the tumor on GRE T2*WI. "
02/01/2009 - "Twenty rabbits bearing VX2 liver tumor underwent MRI enhanced by SPIO (n=10) and Gal-BSA-SPIO (n=10), and the T2 values of the liver and tumor before and after the contrast imaging were measured. "
02/01/2009 - "[Synthesis of Gal-BSA-SPIO and magnetic resonance imaging of ASG receptors in rabbits bearing liver VX2 tumor and human liver]."
|4.||Hepatocellular Carcinoma (Hepatoma)
|1.||Advanced Glycosylation End Products
|2.||Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
|3.||Nitric Oxide (Nitrogen Monoxide)